An evaluation of the TCu 380Ag and the Multiload Cu375.
The TCu 380Ag (Outokumpu Oy, Pori, Finland) and the Multiload Cu375 (Multilan, Organon, Oss, The Netherlands) were evaluated in 1477 women in a multicenter clinical trial. The intrauterine devices showed similar, low-event rates. Cumulative life-table pregnancy rates were less than 1.0, and continuation rates were approximately 90 per 100 women at 1 year after insertion. The risk of subsequent hospitalization or pelvic infection was low.
D000328:Adult; D002986:Clinical Trials as Topic; D004867:Equipment Design; D004869:Equipment Safety; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007435:Intrauterine Devices, Copper / Q000009:adverse effects; D010146:Pain / Q000209:etiology; D010388:Pelvis; D011247:Pregnancy; D011897:Random Allocation; D014592:Uterine Hemorrhage / Q000209:etiology